Jie Lin

发表

Corrigendum: Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer

L. Kiemeney, U. Thorsteinsdóttir, K. Stefánsson, 2009, Nature Genetics.

Cyclin D1 gene polymorphism as a risk factor for oral premalignant lesions.

M. Spitz, S. Lippman, J. Gu, 2006, Carcinogenesis.

Modulation of DNA damage/DNA repair capacity by XPC polymorphisms.

J. Gu, Hushan Yang, Xifeng Wu, 2008, DNA repair.

Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer

Jian Gu, Paolo Vineis, Simonetta Guarrera, 2009, Nature Genetics.

Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17 q 21 . 31

Sebastian M. Armasu, Yurii B. Shvetsov, A. Whittemore, 2013 .

Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31

A. Whittemore, L. Kiemeney, M. Pike, 2013, Nature Communications.

Genetic variants in MicroRNA biosynthesis pathways and binding sites modify ovarian cancer risk, survival, and treatment response.

Dong Liang, Jian Gu, Karen Lu, 2010, Cancer research.

Genetic variants and risk of lung cancer in never smokers: a genome-wide association study.

Zhifu Sun, Feng Chen, Mariza de Andrade, 2010, The Lancet. Oncology.

Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10.

David N. Rider, A. Whittemore, L. Kiemeney, 2014, Cancer research.

Case-control analysis of nucleotide excision repair pathway and the risk of renal cell carcinoma.

Xifeng Wu, C. Wood, Jie Lin, 2008, Carcinogenesis.

Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33.

William Wheeler, Hideo Tanaka, Jianxin Shi, 2014, Human molecular genetics.

Energy Balance, the PI3K-AKT-mTOR Pathway Genes, and the Risk of Bladder Cancer

Xifeng Wu, H. Grossman, C. Dinney, 2010, Cancer Prevention Research.

Energy Balance , the PI 3 K-AKT-mTOR Pathway Genes , and the Risk of Bladder Cancer

Xifeng Wu, H. Grossman, C. Dinney, 2010 .

γ-H2AX level in peripheral blood lymphocytes as a risk predictor for bladder cancer.

Xifeng Wu, Y. Ye, Jie Lin, 2013, Carcinogenesis.

Genetic Variations in the Regulator of G-Protein Signaling Genes Are Associated with Survival in Late-Stage Non-Small Cell Lung Cancer

J. Gu, Xifeng Wu, J. Roth, 2011, PloS one.

The CHRNA5-A3 region on chromosome 15q24-25.1 is a risk factor both for nicotine dependence and for lung cancer.

M. Spitz, Xifeng Wu, C. Amos, 2008, Journal of the National Cancer Institute.

Sensitivity to NNKOAc is associated with renal cancer risk.

Xifeng Wu, C. Wood, Jie Lin, 2009, Carcinogenesis.

MicroRNA target site polymorphisms in the VHL‐HIF1α pathway predict renal cell carcinoma risk

S. Shete, C. Wood, Jie Lin, 2014, Molecular carcinogenesis.

Abstract 4640: Quantification of gamma-H2AX expression in whole blood culture as a risk predictor for renal cell carcinoma

Xifeng Wu, C. Wood, Jie Lin, 2011 .

Genetic variations in regulator of G-protein signaling genes as susceptibility loci for second primary tumor/recurrence in head and neck squamous cell carcinoma.

Edward S. Kim, S. Lippman, Hushan Yang, 2010, Carcinogenesis.

Dietary isothiocyanates, GSTM1, GSTT1, NAT2 polymorphisms and bladder cancer risk

Xifeng Wu, H. Grossman, C. Dinney, 2007, International journal of cancer.

Genetic Variations in MicroRNA-Related Genes Are Novel Susceptibility Loci for Esophageal Cancer Risk

Jian Gu, Yuanqing Ye, Jie Lin, 2008, Cancer Prevention Research.

Polymorphisms in DNA repair genes, smoking, and bladder cancer risk: findings from the international consortium of bladder cancer.

Tony Fletcher, Paolo Vineis, Simonetta Guarrera, 2009, Cancer research.

Kinome expression proﬁling identiﬁes IKBKE as a predictor of overall survival in clear cell renal cell carcinoma patients

Xifeng Wu, P. Tamboli, C. Wood, 2012 .

GENETIC VARIANTS WITHIN THE WNT/ β -CATENIN SIGNALING PATHWAY AS INDICATORS OF BLADDER CANCER RISK

Xifeng Wu, Y. Ye, C. Dinney, 2016 .

Ionizing Radiation – Induced g -H2AX Activity in Whole Blood Culture and the Risk of Lung Cancer Epidemiology,Biomarkers&Prevention

Xifeng Wu, J. Roth, Jie Lin, 2013 .

Personal Permanent Hair Dye Use Is Not Associated with Bladder Cancer Risk: Evidence from a Case-Control Study

Xifeng Wu, H. Grossman, C. Dinney, 2006, Cancer Epidemiology Biomarkers & Prevention.

Depressive Symptoms , Telomere Length and Bladder Cancer 1 Depressive Symptoms and Short Telomere Length Are Associated with Increased Mortality in Bladder Cancer Patients

J. Gu, Xifeng Wu, Y. Ye, 2014 .

A Genome-Wide Association Study Identifies a Locus on Chromosome 14q21 as a Predictor of Leukocyte Telomere Length and as a Marker of Susceptibility for Bladder Cancer

S. Shete, J. Gu, Xifeng Wu, 2011, Cancer Prevention Research.

Roles of tumor suppressor and telomere maintenance genes in cancer and aging--an epidemiological study.

M. Spitz, J. Gu, Xifeng Wu, 2005, Carcinogenesis.

Genotypes, haplotypes and diplotypes of XPC and risk of bladder cancer.

Hushan Yang, Xifeng Wu, H. Grossman, 2006, Carcinogenesis.

Genetic variations in the PI3K/PTEN/AKT/mTOR pathway are associated with clinical outcomes in esophageal cancer patients treated with chemoradiotherapy.

J. Ajani, Hushan Yang, Xifeng Wu, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Genetic Variations in the Sonic Hedgehog Pathway Affect Clinical Outcomes in Non–Muscle-Invasive Bladder Cancer

N. Malats, A. Picornell, M. Kogevinas, 2010, Cancer Prevention Research.

Genetic Susceptibility to Renal Cell Carcinoma: The Role of DNA Double-Strand Break Repair Pathway

Hushan Yang, Xifeng Wu, V. Margulis, 2008, Cancer Epidemiology Biomarkers & Prevention.

Predictors of esophageal cancer risk: Assessment of susceptibility to DNA damage using comet assay

J. Ajani, Xifeng Wu, Jie Lin, 2005, Genes, chromosomes & cancer.

PI3K/PTEN/AKT/mTOR pathway genetic variation predicts toxicity and distant progression in lung cancer patients receiving platinum-based chemotherapy.

M. Spitz, J. Gu, Xifeng Wu, 2011, Lung cancer.

Genetic variations in microRNA-related genes are associated with survival and recurrence in patients with renal cell carcinoma.

Xifeng Wu, P. Tamboli, C. Wood, 2010, Carcinogenesis.

Constitutive Short Telomere Length of Chromosome 17p and 12q but not 11q and 2p Is Associated with an Increased Risk for Esophageal Cancer

J. Ajani, J. Gu, Xifeng Wu, 2009, Cancer Prevention Research.

Telomere Length of Chromosome 17 p and 12 q but not 11 q and 2 p Is Associated with an Increased Risk for Esophageal Cancer

J. Ajani, J. Gu, Xifeng Wu, 2009 .

Genetic Polymorphisms in MicroRNA-Related Genes as Predictors of Clinical Outcomes in Colorectal Adenocarcinoma Patients

L. Ellis, J. Gu, Xifeng Wu, 2012, Clinical Cancer Research.

Single Nucleotide Polymorphisms of microRNA Machinery Genes Modify the Risk of Renal Cell Carcinoma

Jian Gu, Hua Zhao, Yuanqing Ye, 2008, Clinical Cancer Research.

Genetic variations in PI3K-AKT-mTOR pathway and bladder cancer risk.

J. Gu, Hushan Yang, Xifeng Wu, 2009, Carcinogenesis.

Genetic variations in PI 3 K-AKT-mTOR pathway and bladder cancer risk

J. Gu, Hushan Yang, Xifeng Wu, 2009 .

High-Order Interactions among Genetic Variants in DNA Base Excision Repair Pathway Genes and Smoking in Bladder Cancer Susceptibility

Xifeng Wu, H. Grossman, C. Dinney, 2007, Cancer Epidemiology Biomarkers & Prevention.

An Evolutionary Perspective on Single-Nucleotide Polymorphism Screening in Molecular Cancer Epidemiology

Matthew B Schabath, Christopher I Amos, Jie Lin, 2004, Cancer Research.

Lung Cancer Susceptibility and Risk Assessment Models

Xifeng Wu, Jie Lin, X. Pu, 2014 .

Genome-wide association study identifies multiple loci associated with bladder cancer risk.

William Wheeler, Paolo Vineis, Peter Kraft, 2014, Human molecular genetics.

An association between a NQO1 genetic polymorphism and risk of lung cancer.

M. Spitz, Xifeng Wu, Jie Lin, 2005, Mutation research.

Depressive Symptoms and Short Telomere Length Are Associated with Increased Mortality in Bladder Cancer Patients

J. Gu, Xifeng Wu, Y. Ye, 2014, Cancer Epidemiology, Biomarkers & Prevention.

Depressive Symptoms and Short Telomere Length Are Associated with Increased Mortality in Bladder Cancer Patients

J. Gu, Xifeng Wu, Y. Ye, 2014, Cancer Epidemiology, Biomarkers & Prevention.

Germline genetic variations in drug action pathways predict clinical outcomes in advanced lung cancer treated with platinum-based chemotherapy

Joe Y. Chang, M. Spitz, Hushan Yang, 2008, Pharmacogenetics and genomics.

Genetic variations in the transforming growth factor-beta pathway as predictors of survival in advanced non-small cell lung cancer.

M. Spitz, S. Lippman, J. Gu, 2011, Carcinogenesis.

Kinome expression profiling identifies IKBKE as a predictor of overall survival in clear cell renal cell carcinoma patients.

Xifeng Wu, P. Tamboli, C. Wood, 2012, Carcinogenesis.

Ionizing Radiation–Induced γ-H2AX Activity in Whole Blood Culture and the Risk of Lung Cancer

Xifeng Wu, J. Roth, Jie Lin, 2013, Cancer Epidemiology, Biomarkers & Prevention.

Genetic Variations in Epigenetic Genes Are Predictors of Recurrence in Stage I or II Non–Small Cell Lung Cancer Patients

Xifeng Wu, J. Roth, Y. Ye, 2012, Clinical Cancer Research.

Predictive Biomarkers and Personalized Medicine Genetic Variations in Epigenetic Genes Are Predictors of Recurrence in Stage I or II Non – Small Cell Lung Cancer Patients

Xifeng Wu, J. Roth, Y. Ye, 2012 .

A genetic variant near the PMAIP1/Noxa gene is associated with increased bleomycin sensitivity.

L. Kiemeney, M. Spitz, J. Gu, 2011, Human molecular genetics.

Projecting individualized probabilities of developing bladder cancer in white individuals.

M. Spitz, J. Gu, Xifeng Wu, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Bladder cancer risk as modified by family history and smoking

M. Spitz, Xifeng Wu, C. Dinney, 2006, Cancer.

Genetic variants in matrix metalloproteinase genes as disposition factors for ovarian cancer risk, survival, and clinical outcome

Xifeng Wu, Y. Ye, Jie Lin, 2015, Molecular carcinogenesis.

Functional significance of the hepaCAM gene in bladder cancer

Jie Lin, Xiao-hou Wu, C. Luo, 2010, BMC Cancer.

Genetic Variants in the Wnt/β-Catenin Signaling Pathway as Indicators of Bladder Cancer Risk.

Xifeng Wu, Y. Ye, C. Dinney, 2015, The Journal of urology.

Original Article Association between GSTM1 copy number, promoter variants and susceptibility to urinary bladder cancer

B. Ning, Xifeng Wu, Jie Lin, 2012 .

Association between GSTM1 copy number, promoter variants and susceptibility to urinary bladder cancer.

Baitang Ning, Jie Lin, Susan Kadlubar, 2012, International journal of molecular epidemiology and genetics.

A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC14A1, a urea transporter gene on chromosome 18q12.3.

Jian Gu, Nilanjan Chatterjee, Jonine D Figueroa, 2011, Human molecular genetics.

Dietary Intake of Vegetables and Fruits and the Modification Effects of GSTM1 and NAT2 Genotypes on Bladder Cancer Risk

J. Gu, Xifeng Wu, C. Dinney, 2009, Cancer Epidemiology Biomarkers & Prevention.

Role of inflammatory related gene expression in clear cell renal cell carcinoma development and clinical outcomes.

Xifeng Wu, P. Tamboli, C. Wood, 2011, The Journal of urology.

Intake of red meat and heterocyclic amines, metabolic pathway genes and bladder cancer risk

Xifeng Wu, H. Grossman, C. Dinney, 2012, International journal of cancer.

A genome-wide association study identifies a novel susceptibility locus for renal cell carcinoma on 12p11.23.

M. Thun, F. Clavel-Chapelon, E. Riboli, 2012, Human molecular genetics.

Genome-wide association study of survival in non-small cell lung cancer patients receiving platinum-based chemotherapy.

Jian Gu, Joe Y. Chang, Yuanqing Ye, 2011, Journal of the National Cancer Institute.

Energy balance, polymorphisms in the mTOR pathway, and renal cell carcinoma risk.

Xifeng Wu, C. Wood, Jie Lin, 2013, Journal of the National Cancer Institute.

Family History and Risk of Renal Cell Carcinoma: Results from a Case-Control Study and Systematic Meta-Analysis

Xifeng Wu, P. Tamboli, C. Wood, 2009, Cancer Epidemiology Biomarkers & Prevention.

Mitochondrial DNA content: its genetic heritability and association with renal cell carcinoma.

M. Spitz, J. Gu, Xifeng Wu, 2008, Journal of the National Cancer Institute.

Mutagen Sensitivity and Genetic Variants in Nucleotide Excision Repair Pathway: Genotype-Phenotype Correlation

M. Spitz, J. Gu, Xifeng Wu, 2007, Cancer Epidemiology Biomarkers & Prevention.

Mutagen sensitivity has high heritability: evidence from a twin study.

M. Spitz, J. Gu, Xifeng Wu, 2006, Cancer research.

Polymorphisms of folate metabolic genes and susceptibility to bladder cancer: a case-control study.

M. Spitz, Xifeng Wu, I. Gorlov, 2004, Carcinogenesis.

Common genetic variants in cell cycle pathway are associated with survival in stage III-IV non-small-cell lung cancer.

M. Spitz, S. Lippman, J. Gu, 2011, Carcinogenesis.

Systematic evaluation of apoptotic pathway gene polymorphisms and lung cancer risk.

S. Lippman, J. Gu, Xifeng Wu, 2012, Carcinogenesis.

Genetic Variants in TGF-β Pathway Are Associated with Ovarian Cancer Risk

Dong Liang, Karen Lu, Jie Lin, 2011, PloS one.

Matrix Metalloproteinase Polymorphisms Are Associated with Bladder Cancer Invasiveness

Jian Gu, Jie Lin, Xifeng Wu, 2007, Clinical Cancer Research.

Matrix metalloproteinase polymorphisms are associated with bladder cancer invasiveness.

J. Gu, Xifeng Wu, H. Grossman, 2007, Clinical cancer research : an official journal of the American Association for Cancer Research.

Hepatocellular carcinoma risk prediction model for the general population: the predictive power of transaminases.

Xifeng Wu, Y. Ye, Jie Lin, 2012, Journal of the National Cancer Institute.

A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC 14 A 1 , a urea transporter gene on chromosome 18 q 12 . 3

M. Thun, N. Malats, M. Kogevinas, 2011 .

Risk of urinary bladder cancer: a case-control analysis of industry and occupation

Xifeng Wu, Jie Lin, A. Cassidy, 2009, BMC Cancer.

Plasma vitamins E and A and risk of bladder cancer: a case–control analysis

Xifeng Wu, C. Dinney, Jie Lin, 2008, Cancer Causes and Control.

Interplay between mutagen sensitivity and epidemiological factors in modulatinglung cancer risk

M. Spitz, Xifeng Wu, C. Amos, 2006, International journal of cancer.

Deficiency of cell cycle checkpoints and DNA repair system predispose individuals to esophageal cancer.

J. Ajani, Hushan Yang, Xifeng Wu, 2006, Mutation research.

Urinary tract diseases and bladder cancer risk: a case–control study

Jie Lin, Xifeng Wu, Xifeng Wu, 2007, Cancer Causes & Control.

A multiplexed, particle‐based flow cytometric assay identified plasma matrix metalloproteinase‐7 to be associated with cancer‐related death among patients with bladder cancer

Xifeng Wu, C. Dinney, Jie Lin, 2010, Cancer.

ABO blood types and cancer risk--a cohort study of 339,432 subjects in Taiwan.

Xifeng Wu, W. Chow, Jie Lin, 2015, Cancer epidemiology.

Genetic susceptibility to esophageal cancer: the role of the nucleotide excision repair pathway.

J. Ajani, Xifeng Wu, Jie Lin, 2009, Carcinogenesis.

Genetic Variations in Glutathione Pathway Genes Predict Cancer Recurrence in Patients Treated with Transurethral Resection and Bacillus Calmette–Guerin Instillation for Non-muscle Invasive Bladder Cancer

Xifeng Wu, Y. Ye, C. Dinney, 2015, Annals of Surgical Oncology.

GSTM1 copy number and promoter haplotype as predictors for risk of recurrence and/or second primary tumor in patients with head and neck cancer

B. Ning, Xifeng Wu, Jie Lin, 2013, Pharmacogenomics and personalized medicine.

GSTM 1 copy number and promoter haplotype as predictors for risk of recurrence and / or second primary tumor in patients with head and neck cancer

B. Ning, Xifeng Wu, Jie Lin, 2013 .

A Modified Host Cell Reactivation Assay to Measure DNA Repair Capacity for Removing 4-Aminobiphenyl Adducts: A Pilot Study of Bladder Cancer

M. Spitz, Xifeng Wu, Jie Lin, 2005, Cancer Epidemiology Biomarkers & Prevention.

Single Nucleotide Polymorphisms of microRNA Machinery Genes Modify the Risk of Renal Cell Carcinoma

J. Gu, Hushan Yang, Xifeng Wu, 2008, Clinical Cancer Research.

Hsa-miR-9 methylation status is associated with cancer development and metastatic recurrence in patients with clear cell renal cell carcinoma

J. Gu, Xifeng Wu, P. Tamboli, 2010, Oncogene.

Identification of polymorphisms in ultraconserved elements associated with clinical outcomes in locally advanced colorectal adenocarcinoma

L. Ellis, J. Gu, Xifeng Wu, 2012, Cancer.

Genetic variants within ultraconserved elements and susceptibility to right- and left-sided colorectal adenocarcinoma.

L. Ellis, J. Gu, Xifeng Wu, 2012, Carcinogenesis.

MicroRNA target site polymorphisms in the VHL‐HIF1α pathway predict renal cell carcinoma risk

S. Shete, C. Wood, Jie Lin, 2014, Molecular carcinogenesis.

γ-H2AX level in peripheral blood lymphocytes as a risk predictor for bladder cancer.

Xifeng Wu, Jie Lin, D. Chang, 2013, Carcinogenesis.

Systematic evaluation of apoptotic pathway gene polymorphisms and lung cancer risk.

S. Lippman, J. Gu, Xifeng Wu, 2012, Carcinogenesis.

Genetic Variations in MicroRNA-Related Genes Are Novel Susceptibility Loci for Esophageal Cancer Risk

Kenneth K Wang, J. Ajani, J. Gu, 2008, Cancer Prevention Research.

Genetic susceptibility to esophageal cancer: the role of the nucleotide excision repair pathway.

J. Ajani, Xifeng Wu, Jie Lin, 2009, Carcinogenesis.

Case-control analysis of nucleotide excision repair pathway and the risk of renal cell carcinoma.

Xifeng Wu, C. Wood, Jie Lin, 2008, Carcinogenesis.

The CHRNA5-A3 region on chromosome 15q24-25.1 is a risk factor both for nicotine dependence and for lung cancer.

Christopher I Amos, Jie Lin, Xifeng Wu, 2008, Journal of the National Cancer Institute.

Depressive Symptoms and Short Telomere Length Are Associated with Increased Mortality in Bladder Cancer Patients

J. Gu, Xifeng Wu, Jie Lin, 2014 .

Genetic variants in MicroRNA biosynthesis pathways and binding sites modify ovarian cancer risk, survival, and treatment response.

J. Gu, Xifeng Wu, Jie Lin, 2010, Cancer research.

Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33.

David M. Thomas, Krista A. Zanetti, Geoffrey S. Tobias, 2014, Human molecular genetics.

Energy Balance, the PI3K-AKT-mTOR Pathway Genes, and the Risk of Bladder Cancer

Xifeng Wu, H. Grossman, C. Dinney, 2010, Cancer Prevention Research.

Genetic variations in microRNA-related genes are associated with survival and recurrence in patients with renal cell carcinoma.

Xifeng Wu, P. Tamboli, C. Wood, 2010, Carcinogenesis.

Aryl hydrocarbon receptor involved in Th17/Treg imbalance in chronic hepatitis B via the AhR– ROR γ t–FoxP3 axis

Jie Lin, Ru-Yan Zhang, Huaie Liu, 2022 .